Jiangxi Rimag Group Co (HKSE:02522) EBIT : HK$17.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Jiangxi Rimag Group Co EBIT?

Jiangxi Rimag Group Co's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$16.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$17.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jiangxi Rimag Group Co's annualized ROC % for the quarter that ended in Jun. 2024 was 0.45%. Jiangxi Rimag Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 2.30%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jiangxi Rimag Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 0.08%.

Jiangxi Rimag Group Co EBIT Historical Data

The historical data trend for Jiangxi Rimag Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Rimag Group Co EBIT Chart

Jiangxi Rimag Group Co Annual Data

Trend

Dec21

Dec22

Dec23

EBIT

-367.94

42.74

74.57

Jiangxi Rimag Group Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
EBIT	-	-	74.13	0.43	16.60

Competitive Comparison of Jiangxi Rimag Group Co's EBIT

For the Medical Care Facilities subindustry, Jiangxi Rimag Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangxi Rimag Group Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jiangxi Rimag Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jiangxi Rimag Group Co's EV-to-EBIT falls into.

Jiangxi Rimag Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$17.0 Mil.

Jiangxi Rimag Group Co (HKSE:02522) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jiangxi Rimag Group Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	36.046 * ( 1 - 78% )	/	( (1690.156	+	1841.805)	/ 2 )
=	7.93012	/	1765.9805
=	0.45 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2054.836	-	154.318	-	( 210.362	-	max(0, 345.835	-	678.667	+	210.362	))
=	1690.156

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2345.763	-	172.351	-	( 331.607	-	max(0, 402.038	-	884.459	+	331.607	))
=	1841.805

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Jiangxi Rimag Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	33.208	/	( ( (1081.743 + max(299.036, 0))	+	(1148.257 + max(356.283, 0)) )	/	2 )
=	33.208	/	( ( 1380.779	+	1504.54 )	/	2 )
=	33.208	/	1442.6595
=	2.30 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(363.165	+	5.833	+	95.648)	-	(154.318	+	0	+	11.292)
=	299.036

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(465.902	+	5.558	+	77.211)	-	(172.351	+	0	+	20.037)
=	356.283

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jiangxi Rimag Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	17.038	/	21137.609
	=	0.08 %

Jiangxi Rimag Group Co EBIT Related Terms

Thank you for viewing the detailed overview of Jiangxi Rimag Group Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Rimag Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jiangxi Rimag Group Co Ltd (HKSE:02522) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Minzuyuan Road, Building 2, 2 Minzuyuan, 3rd Floor, Chaoyang District, Beijing, CHN

Website

https://www.rimag.com.cn

Jiangxi Rimag Group Co Ltd is a leading medical group specializing in medical imaging in China. the company generates revenue mainly through the following medical imaging services and solutions: Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services. The Imaging Center Services include examination and diagnostic services to patients and other healthcare consumers via its flagship imaging centers, such as MRI, CT, PET, X-ray, ultrasound and mammography.

Executives

Beijing Goldman Sachs Consulting Co., Ltd.	2101 Beneficial owner
Goldman Sachs & Co. Llc	2201 Interest of corporation controlled by you
Goldman Sachs Holdings (mauritius) Limited	2201 Interest of corporation controlled by you
Gs Asian Venture (delaware) L.l.c.	2201 Interest of corporation controlled by you
Gssg Holdings Llc	2201 Interest of corporation controlled by you
Special Situations Investing Group Iii, Inc.	2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Tiger Strategic Investments Ltd	2201 Interest of corporation controlled by you

Jiangxi Rimag Group Co Headlines

No Headlines